BOSTON--(BUSINESS WIRE)--PHT Corporation announced that Chelsea Therapeutics is using PHT’s LogPad® System and SitePad® Tablet for its ongoing clinical study in Parkinson’s disease patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback